SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-029543
Filing Date
2020-06-16
Accepted
2020-06-16 16:39:40
Documents
14
Period of Report
2020-06-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K - 2020 ANNUAL MEETING arna-8k_20200612.htm   iXBRL 8-K 102924
2 CERTIFICATE OF AMENDMENT NO. 5 OF THE FIFTH AMENDED AND RESTATED CERTIFICATE OF arna-ex31_7.htm EX-3.1 8013
3 AMENDED AND RESTATED BYLAWS OF ARENA arna-ex32_6.htm EX-3.2 108556
  Complete submission text file 0001564590-20-029543.txt   388057

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA arna-20200612.xsd EX-101.SCH 5784
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE arna-20200612_lab.xml EX-101.LAB 19459
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arna-20200612_pre.xml EX-101.PRE 11633
15 EXTRACTED XBRL INSTANCE DOCUMENT arna-8k_20200612_htm.xml XML 3561
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31161 | Film No.: 20966869
SIC: 2834 Pharmaceutical Preparations